financetom
Business
financetom
/
Business
/
Airbus delivers 71 jets in March
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Airbus delivers 71 jets in March
Apr 9, 2025 9:38 AM

April 9 (Reuters) - Airbus delivered 71 jets in March,

the planemaker confirmed on Wednesday, bringing first-quarter

deliveries to 136, down from 142 a year earlier.

The world's largest planemaker also booked 280 orders for a

net total of 204 after adjusting for cancellations.

The delivery total for March confirms a figure previously

reported by Reuters.

Airbus has warned that first-quarter deliveries would be

constrained mainly by a shortage of engines from biggest

supplier CFM, jointly owned by GE Aerospace and Safran

, which brought forward some supplies to the previous

quarter to help Airbus to meet 2024 targets.

The European planemaker is targeting 820 deliveries for the

whole year.

Analysts say the rhythm of plane deliveries, which account

for most of the company's revenue, will be under scrutiny in the

coming months as aerospace and other industries gear up for

possible new trade tariffs that could affect parts and raw

materials.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
United Therapeutics Insider Sold Shares Worth $2,585,601, According to a Recent SEC Filing
United Therapeutics Insider Sold Shares Worth $2,585,601, According to a Recent SEC Filing
May 6, 2024
04:43 PM EDT, 05/06/2024 (MT Newswires) -- Judy D. Olian, Director, on May 03, 2024, sold 10,000 shares in United Therapeutics ( UTHR ) for $2,585,601. Following the Form 4 filing with the SEC, Olian has control over a total of 7,305 shares of the company, with 7,305 shares held directly. SEC Filing: https://www.sec.gov/Archives/edgar/data/1082554/000141588924012330/xslF345X03/form4-05062024_040507.xml ...
United Therapeutics Insider Sold Shares Worth $582,195, According to a Recent SEC Filing
United Therapeutics Insider Sold Shares Worth $582,195, According to a Recent SEC Filing
May 6, 2024
04:43 PM EDT, 05/06/2024 (MT Newswires) -- Christopher Causey, Director, on May 03, 2024, sold 2,240 shares in United Therapeutics ( UTHR ) for $582,195. Following the Form 4 filing with the SEC, Causey has control over a total of 4,185 shares of the company, with 4,185 shares held directly. SEC Filing: https://www.sec.gov/Archives/edgar/data/1082554/000141588924012329/xslF345X03/form4-05062024_040504.xml ...
Root Insider Sold Shares Worth $805,767, According to a Recent SEC Filing
Root Insider Sold Shares Worth $805,767, According to a Recent SEC Filing
May 6, 2024
04:42 PM EDT, 05/06/2024 (MT Newswires) -- Meyer Malka, 10% Owner, on May 02, 2024, sold 13,300 shares in Root (ROOT) for $805,767. Following the Form 4 filing with the SEC, Malka has control over a total of 43,107 shares of the company, with 43,107 controlled indirectly. SEC Filing: https://www.sec.gov/Archives/edgar/data/1788882/000110465924057469/xslF345X03/tm2413520-1_4seq1.xml Price: 57.20, Change: +0.58, Percent Change: +1.02 ...
Williams Q1 Adjusted Earnings Rise, Revenue Declines; Reaffirms 2024 Adjusted EPS Outlook
Williams Q1 Adjusted Earnings Rise, Revenue Declines; Reaffirms 2024 Adjusted EPS Outlook
May 6, 2024
04:42 PM EDT, 05/06/2024 (MT Newswires) -- Williams (WMB) reported Q1 adjusted net income Monday of $0.59 per diluted share, up from $0.56 a year earlier. Analysts polled by Capital IQ expected $0.49. Revenue for the quarter ended March 31 was $2.77 billion, down from $3.08 billion a year earlier. Analysts polled by Capital IQ expected $2.69 billion. The pipeline...
Copyright 2023-2025 - www.financetom.com All Rights Reserved